Skip to content

Study on the therapeutic effect of nerve regulation and massage in the mid-term rehabilitation after ischemic stroke

Study on the therapeutic effect of nerve regulation and massage in the mid-term rehabilitation after ischemic stroke

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035979
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as ischemic stroke by clinical evaluation and comprehensive imaging examinations meet the diagnostic criteria for ischemic stroke; 2. Fugl-Meyer motor function score is confirmed as motor dysfunction; 3. Aged 18-70 years, no gender limit; 4. No cognitive impairment or communication impairment, with a score of 27 or more in the Simple Intelligence State Examination (MMSE); 5. The first onset, the course of illness is from January to June.

Exclusion criteria

Exclusion criteria: 1. Those who have serious systemic diseases such as cardiopulmonary disease and cannot tolerate rehabilitation treatment; 2. Patients with diagnosed psychosis, major depression (suicidal tendency) or epilepsy, and those with family history of psychosis or epilepsy; 3. Existence of serious systemic diseases such as diabetes and uremia; 4. Severe joint contracture; 5. Suffer from any cause of consciousness disorder; 6. According to safety guidelines, there are contraindications for transcranial direct current/magnetic stimulation (TMS/tDCS) and functional magnetic resonance (fMRI) examinations such as: metal foreign bodies in the body or other electronic devices implanted in the body; 7. Defects in hearing or vision may affect assessment and treatment; 8. Use drugs that change the excitability of the cerebral cortex (antiepileptic drugs, sedative hypnotic drugs, etc.).

Design outcomes

Primary

MeasureTime frame
Change of Fugl-Meyer motor function score of affected upper limb;

Secondary

MeasureTime frame
Upper limb WOLF motor function score;Modified Ashworth score;Berg Balance Scale;International Classification of Functioning, Disability and Health (ICF) General Combination;Electrophysiological testing of the affected upper limb;FMRI;fNIRS;

Countries

China

Contacts

Public ContactDongsheng Xu

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

dxu0927@163.com+86 13017103619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026